NMES + High Protein for Brain Hemorrhage Recovery
Trial Summary
What is the purpose of this trial?
The study purpose is to investigate the hypothesis that in adults with SAH, early neuromuscular electrical stimulation (NMES) and high protein supplementation (HPRO) will improve muscle mass, metabolic and inflammatory biomarker profiles, compared to SAH controls receiving standard of care interventions for nutrition and mobilization. The investigators will accomplish this by studying the effects of a high protein (HPRO) nutritional treatment as well as NMES intervention have upon muscle wasting and motor strength acutely after SAH. This will be addressed in a prospective trial of SAH patients receiving HRPO with NMES as compared to age and severity-matched SAH patients undergoing standard of care interventions for nutrition and mobilization. Additionally, the study will investigate the impact HPRO and NMES interventions have upon inflammatory cytokines and markers of energy balance. Results of this study will establish evidence for precision nutrition plus early exercise to mitigate the catabolic and inflammatory state produced by SAH to improve muscle, metabolic, and health recovery outcomes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment NMES + High Protein for Brain Hemorrhage Recovery?
Research shows that combining neuromuscular electrical stimulation (NMES) with high protein intake can help preserve muscle mass in older adults during periods of inactivity, like bed rest. This suggests that NMES and high protein might help maintain muscle mass during recovery from brain hemorrhage, although it may not improve muscle function.12345
Is NMES combined with high protein supplementation safe for humans?
Research shows that combining neuromuscular electrical stimulation (NMES) with high protein supplementation has been studied in various conditions, including critical illness and bed rest in older adults, without significant safety concerns reported. However, the effectiveness and specific safety profile may vary depending on the condition being treated.12346
How does the NMES + High Protein treatment differ from other treatments for brain hemorrhage recovery?
The NMES + High Protein treatment is unique because it combines neuromuscular electrical stimulation (NMES) with high-protein supplementation to potentially preserve neuromotor and cognitive function after a brain hemorrhage, unlike standard care which may not focus on these specific interventions.678910
Research Team
Neeraj Badjatia, MD
Principal Investigator
University of Maryland, Baltimore
Eligibility Criteria
Adults aged 25-80 with recent aneurysmal subarachnoid hemorrhage (SAH), who've had aneurysm repair within 48 hours, and will stay in intensive care for over 72 hours. Participants should have a certain severity of SAH but not be too unwell or have conditions like severe kidney issues, muscle disorders, active cancer, or allergies to whey protein.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive NMES and/or HPRO interventions to improve muscle mass and metabolic profiles
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- High Protein Supplementation
- NMES
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Maryland, Baltimore
Lead Sponsor